{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:53:17Z","timestamp":1790751197082,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.rdc.2016.03.002","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T19:36:25Z","timestamp":1466969785000},"page":"419-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":223,"title":["Autoantibodies in Sj\u00f6gren\u2019s Syndrome"],"prefix":"10.1016","volume":"42","author":[{"given":"Anum","family":"Fayyaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biji T.","family":"Kurien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Hal","family":"Scofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2016.03.002_bib1","first-page":"549107","article-title":"Current concepts: mouse models of Sj\u00f6gren's syndrome","volume":"2011","author":"Lavoie","year":"2011","journal-title":"J\u00a0Biomed Biotechnol"},{"issue":"4","key":"10.1016\/j.rdc.2016.03.002_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1586\/1744666X.2014.883920","article-title":"The value of animal models to study immunopathology of primary human Sj\u00f6gren's syndrome symptoms","volume":"10","author":"Donate","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2016.03.002_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar3313","article-title":"Sj\u00f6gren's syndrome: studying the disease in mice","volume":"13","author":"Delaleu","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"9420","key":"10.1016\/j.rdc.2016.03.002_bib4","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0140-6736(04)16154-0","article-title":"Autoantibodies as predictors of disease","volume":"363","author":"Scofield","year":"2004","journal-title":"Lancet"},{"issue":"2\u20133","key":"10.1016\/j.rdc.2016.03.002_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF02099027","article-title":"Passively acquired autoimmunity and the maternal fetal dyad in systemic lupus erythematosus","volume":"9","author":"Buyon","year":"1986","journal-title":"Springer Semin Immunopathol"},{"issue":"6","key":"10.1016\/j.rdc.2016.03.002_bib6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.2008.088054","article-title":"Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus","volume":"68","author":"Rivera","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.rdc.2016.03.002_bib7","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/art.39214","article-title":"Prediction of Sj\u00f6gren's syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling","volume":"67","author":"Theander","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"17","key":"10.1016\/j.rdc.2016.03.002_bib8","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1001\/jama.2013.278448","article-title":"Autoantibodies present before symptom onset in primary Sj\u00f6gren syndrome","volume":"310","author":"Jonsson","year":"2013","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.rdc.2016.03.002_bib9","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.rdc.2016.03.002_bib10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2016.03.002_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary Sj\u00f6gren's syndrome","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2016.03.002_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.semarthrit.2010.07.006","article-title":"Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sj\u00f6gren's Syndrome: a retrospective analysis of 65 patients in the Netherlands","volume":"40","author":"ter Borg","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2016.03.002_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2010.05.004","article-title":"Immunological profile in primary Sj\u00f6gren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease","volume":"9","author":"Fauchais","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.rdc.2016.03.002_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10067-005-0059-3","article-title":"Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sj\u00f6gren's syndrome: prevalence and clinical significance in 335 patients","volume":"25","author":"Nardi","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2016.03.002_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0896-8411(89)90160-1","article-title":"Molecular structure of the La and Ro autoantigens and their use in autoimmune diagnostics","volume":"2","author":"Keene","year":"1989","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08916930400022954","article-title":"Anti-Ro\/SSA and La\/SSB antibodies","volume":"38","author":"Franceschini","year":"2005","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.rdc.2016.03.002_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/RHU.0b013e3182675e4f","article-title":"Relation of sensory peripheral neuropathy in Sj\u00f6gren syndrome to anti-Ro\/SSA","volume":"18","author":"Scofield","year":"2012","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2016.03.002_bib18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2012-202565","article-title":"Classification criteria for Sj\u00f6gren's syndrome: we actually need to definitively resolve the long debate on the issue","volume":"72","author":"Vitali","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2016.03.002_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/ard.43.2.243","article-title":"Autoantibodies in the sicca syndrome (primary Sj\u00f6gren's syndrome)","volume":"43","author":"Elkon","year":"1984","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.rdc.2016.03.002_bib20","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1136\/annrheumdis-2014-206683","article-title":"The SSB-positive\/SSA-negative antibody profile is not associated with key phenotypic features of Sj\u00f6gren's syndrome","volume":"74","author":"Baer","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2016.03.002_bib21","first-page":"181","article-title":"Anti-La (SS-B): a diagnostic criterion for Sj\u00f6gren's syndrome?","volume":"7","author":"Venables","year":"1989","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2016.03.002_bib22","first-page":"17","article-title":"The autoantibody profile in Sj\u00f6gren's syndrome","volume":"60","author":"Manoussakis","year":"1988","journal-title":"Ter Arkh"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000024423","article-title":"Sj\u00f6gren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects","volume":"123","author":"Mavragani","year":"2000","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2016.03.002_bib24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/ard.61.5.398","article-title":"Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro\/SSA, La\/SSB and their linear epitopes in primary Sj\u00f6gren's syndrome (pSS): a European multicentre study","volume":"61","author":"Tzioufas","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2016.03.002_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","article-title":"Primary Sj\u00f6gren syndrome in Spain: clinical and immunologic expression in 1010 patients","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.rdc.2016.03.002_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/rheumatology\/38.3.245","article-title":"Primary Sj\u00f6gren's syndrome in the North East of England: a long-term follow-up study","volume":"38","author":"Davidson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.rdc.2016.03.002_bib27","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.autrev.2015.03.004","article-title":"Clinical picture, outcome and predictive factors of lymphoma in Sj\u00f6gren syndrome","volume":"14","author":"Papageorgiou","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.rdc.2016.03.002_bib28","first-page":"1905","article-title":"Clinical course of primary Sj\u00f6gren's syndrome: salivary, oral, and serologic aspects","volume":"27","author":"Gannot","year":"2000","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2016.03.002_bib29","first-page":"647","article-title":"Bronchiectasis in primary Sj\u00f6gren's syndrome: prevalence and clinical significance","volume":"28","author":"Soto-Cardenas","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2016.03.002_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0034-1371529","article-title":"Pulmonary involvement in Sj\u00f6gren syndrome","volume":"35","author":"Kreider","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.rdc.2016.03.002_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/gene.2009.20","article-title":"Peripheral blood gene expression profiling in Sj\u00f6gren's syndrome","volume":"10","author":"Emamian","year":"2009","journal-title":"Genes Immun"},{"issue":"4","key":"10.1016\/j.rdc.2016.03.002_bib32","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaut.2012.07.003","article-title":"Secreted human Ro52 autoantibody proteomes express a restricted set of public clonotypes","volume":"39","author":"Arentz","year":"2012","journal-title":"J\u00a0Autoimmun"},{"issue":"2","key":"10.1016\/j.rdc.2016.03.002_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/cei.12171","article-title":"An immunodominant La\/SSB autoantibody proteome derives from public clonotypes","volume":"174","author":"Thurgood","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clim.2013.03.015","article-title":"Long-term Ro60 humoral autoimmunity in primary Sj\u00f6gren's syndrome is maintained by rapid clonal turnover","volume":"148","author":"Lindop","year":"2013","journal-title":"Clin Immunol"},{"issue":"12","key":"10.1016\/j.rdc.2016.03.002_bib35","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1002\/art.38872","article-title":"Antibody-secreting cell specificity in labial salivary glands reflects the clinical presentation and serology in patients with Sj\u00f6gren's syndrome","volume":"66","author":"Maier-Moore","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2016.03.002_bib36","doi-asserted-by":"crossref","first-page":"544","DOI":"10.7326\/0003-4819-120-7-199404010-00003","article-title":"Autoantibody-associated congenital heart block: outcome in mothers and children","volume":"120","author":"Waltuck","year":"1994","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.yexcr.2014.01.003","article-title":"Molecular mechanisms of congenital heart block","volume":"325","author":"Ambrosi","year":"2014","journal-title":"Exp Cell Res"},{"issue":"8","key":"10.1016\/j.rdc.2016.03.002_bib38","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","article-title":"Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women","volume":"44","author":"Brucato","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2016.03.002_bib39","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0735-1097(98)00161-2","article-title":"Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry","volume":"31","author":"Buyon","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.rdc.2016.03.002_bib40","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1191\/0961203303lu425xx","article-title":"Birth order, gender and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling","volume":"12","author":"Solomon","year":"2003","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.rdc.2016.03.002_bib41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/1529-0131(200102)44:2<487::AID-ANR70>3.0.CO;2-D","article-title":"The rate of recurrence of isolated congenital heart block: a population-based study","volume":"44","author":"Julkunen","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.rdc.2016.03.002_bib42","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/art.24768","article-title":"Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal\/fetal risk factors","volume":"60","author":"Llanos","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2016.03.002_bib43","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/annrheumdis-2011-200207","article-title":"Development of heart block in children of SSA\/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern","volume":"71","author":"Ambrosi","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2016.03.002_bib44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1056\/NEJM198501103120206","article-title":"Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue","volume":"312","author":"Litsey","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.rdc.2016.03.002_bib45","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0002-9343(87)90918-1","article-title":"Cardiac immunoglobulin deposition in congenital heart block associated with maternal anti-Ro autoantibodies","volume":"83","author":"Lee","year":"1987","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.rdc.2016.03.002_bib46","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.4049\/jimmunol.176.10.6277","article-title":"The Sj\u00f6gren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death","volume":"176","author":"Espinosa","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"8","key":"10.1016\/j.rdc.2016.03.002_bib47","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1084\/jem.20090585","article-title":"Loss of the lupus autoantigen Ro52\/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway","volume":"206","author":"Espinosa","year":"2009","journal-title":"J\u00a0Exp Med"},{"issue":"12","key":"10.1016\/j.rdc.2016.03.002_bib48","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.4049\/jimmunol.0804121","article-title":"Gene disruption study reveals a nonredundant role for TRIM21\/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts","volume":"182","author":"Yoshimi","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2016.03.002_bib49","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.4049\/jimmunol.0803126","article-title":"TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response","volume":"182","author":"Yang","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.rdc.2016.03.002_bib50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00109-004-0529-0","article-title":"The Ro 60\u00a0kDa autoantigen: insights into cellular function and role in autoimmunity","volume":"82","author":"Chen","year":"2004","journal-title":"J\u00a0Mol Med (Berl)"},{"issue":"24","key":"10.1016\/j.rdc.2016.03.002_bib51","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.cub.2003.11.028","article-title":"The Ro autoantigen binds misfolded U2 small nuclear RNAs and assists mammalian cell survival after UV irradiation","volume":"13","author":"Chen","year":"2003","journal-title":"Curr Biol"},{"issue":"4","key":"10.1016\/j.rdc.2016.03.002_bib52","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1084\/jem.179.4.1317","article-title":"Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes","volume":"179","author":"Casciola-Rosen","year":"1994","journal-title":"J\u00a0Exp Med"},{"issue":"9","key":"10.1016\/j.rdc.2016.03.002_bib53","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.4049\/jimmunol.161.9.5061","article-title":"Accessibility of SSA\/Ro and SSB\/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes","volume":"161","author":"Miranda","year":"1998","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib54","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2249.2007.03331.x","article-title":"Different temporal expression of immunodominant Ro60\/60\u00a0kDa-SSA and La\/SSB apotopes","volume":"148","author":"Reed","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/art.11430","article-title":"Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage\/fibroblast crosstalk in the pathologic cascade leading to congenital heart block","volume":"50","author":"Clancy","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2016.03.002_bib56","first-page":"2413","article-title":"Impaired clearance of apoptotic cardiocytes is linked to anti-SSA\/Ro and -SSB\/La antibodies in the pathogenesis of congenital heart block","volume":"116","author":"Clancy","year":"2006","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.rdc.2016.03.002_bib57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/jaut.2001.0524","article-title":"Induction of salivary gland epithelial cell injury in Sj\u00f6gren's syndrome: in\u00a0vitro assessment of T\u00a0cell-derived cytokines and Fas protein expression","volume":"17","author":"Abu-Helu","year":"2001","journal-title":"J\u00a0Autoimmun"},{"issue":"3","key":"10.1016\/j.rdc.2016.03.002_bib58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaut.2010.06.011","article-title":"The role of intrinsic epithelial activation in the pathogenesis of Sj\u00f6gren's syndrome","volume":"35","author":"Manoussakis","year":"2010","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.rdc.2016.03.002_bib59","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1365-3083.2002.01072_79.x","article-title":"Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sj\u00f6gren's syndrome","volume":"56","author":"Ohlsson","year":"2002","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2016.03.002_bib60","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2249.1998.00705.x","article-title":"Modes of epithelial cell death and repair in Sj\u00f6gren's syndrome (SS)","volume":"114","author":"Polihronis","year":"1998","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1203\/00006450-199807000-00002","article-title":"Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model","volume":"44","author":"Boutjdir","year":"1998","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1016\/j.rdc.2016.03.002_bib62","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.RES.80.3.354","article-title":"Arrhythmogenicity of IgG and anti-52-kD SSA\/Ro affinity-purified antibodies from mothers of children with congenital heart block","volume":"80","author":"Boutjdir","year":"1997","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.20041859","article-title":"Ro\/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block","volume":"201","author":"Salomonsson","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib64","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4049\/jimmunol.1100122","article-title":"beta2-glycoprotein I and protection from anti-SSA\/Ro60-associated cardiac manifestations of neonatal lupus","volume":"187","author":"Reed","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.rdc.2016.03.002_bib65","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.4049\/jimmunol.1101288","article-title":"Binding of anti-SSA antibodies to apoptotic fetal cardiocytes stimulates urokinase plasminogen activator (uPA)\/uPA receptor-dependent activation of TGF-beta and potentiates fibrosis","volume":"187","author":"Briassouli","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"1\u20132","key":"10.1016\/j.rdc.2016.03.002_bib66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaut.2012.03.001","article-title":"Subgroups of Sj\u00f6gren syndrome patients according to serological profiles","volume":"39","author":"Bournia","year":"2012","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.rdc.2016.03.002_bib67","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s10875-011-9553-3","article-title":"Active immunological profile is associated with systemic Sj\u00f6gren's syndrome","volume":"31","author":"Martel","year":"2011","journal-title":"J\u00a0Clin Immunol"},{"issue":"1\u20132","key":"10.1016\/j.rdc.2016.03.002_bib68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaut.2011.12.006","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a critical review","volume":"39","author":"Baldini","year":"2012","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1756-185X.2009.01444.x","article-title":"Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sj\u00f6gren's syndrome","volume":"13","author":"Huo","year":"2010","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10067-011-1789-z","article-title":"Clinical significance and diagnostic usefulness of anti-centromere antibody in Sj\u00f6gren's syndrome","volume":"31","author":"Kitagawa","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib71","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/03009740802366043","article-title":"IgA rheumatoid factor in primary Sj\u00f6gren's syndrome","volume":"38","author":"Peen","year":"2009","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2016.03.002_bib72","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/bjo.2011.202812","article-title":"Prognostic factors for the clinical severity of keratoconjunctivitis sicca in patients with Sj\u00f6gren's syndrome","volume":"96","author":"Chung","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"13","key":"10.1016\/j.rdc.2016.03.002_bib73","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1073\/pnas.95.13.7538","article-title":"Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sj\u00f6gren's syndrome","volume":"95","author":"Robinson","year":"1998","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.rdc.2016.03.002_bib74","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-0722.2010.00716.x","article-title":"Cholinergic autoantibodies from primary Sj\u00f6gren's syndrome modulate submandibular gland Na+\/K+-ATPase activity via prostaglandin E2 and cyclic AMP","volume":"118","author":"Passafaro","year":"2010","journal-title":"Eur J Oral Sci"},{"issue":"5","key":"10.1016\/j.rdc.2016.03.002_bib75","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.archoralbio.2010.08.017","article-title":"Anti-M(3) muscarinic cholinergic autoantibodies from patients with primary Sj\u00f6gren's syndrome trigger production of matrix metalloproteinase-3 (MMP-3) and prostaglandin E(2) (PGE(2)) from the submandibular glands","volume":"56","author":"Reina","year":"2011","journal-title":"Arch Oral Biol"},{"issue":"5","key":"10.1016\/j.rdc.2016.03.002_bib76","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0022034515577813","article-title":"Effect of antimuscarinic autoantibodies in primary Sj\u00f6gren's syndrome","volume":"94","author":"Kim","year":"2015","journal-title":"J\u00a0Dent Res"},{"issue":"5","key":"10.1016\/j.rdc.2016.03.002_bib77","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/art.30282","article-title":"Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sj\u00f6gren's syndrome","volume":"63","author":"Park","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2016.03.002_bib78","first-page":"321","article-title":"Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sj\u00f6gren syndrome","volume":"42","author":"Bacman","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.rdc.2016.03.002_bib79","first-page":"1342","article-title":"Failure to detect antibodies to extracellular loop peptides of the muscarinic M3 receptor in primary Sj\u00f6gren's syndrome","volume":"29","author":"Cavill","year":"2002","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2016.03.002_bib80","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P","article-title":"Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sj\u00f6gren's syndrome","volume":"43","author":"Waterman","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2016.03.002_bib81","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/ar2958","article-title":"Anticentromere antibody positive Sj\u00f6gren's Syndrome: a retrospective descriptive analysis","volume":"12","author":"Bournia","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.rdc.2016.03.002_bib82","first-page":"2238","article-title":"Clinical and laboratory features of anticentromere antibody positive primary Sj\u00f6gren's syndrome","volume":"28","author":"Katano","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2016.03.002_bib83","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2230.1994.tb01199.x","article-title":"Anticentromere antibodies (ACA): clinical distribution and disease specificity","volume":"19","author":"Chan","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.rdc.2016.03.002_bib84","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0248-8663(10)80020-7","article-title":"Anti-centromere antibodies. Study of 67 positive sera","volume":"13","author":"Renier","year":"1992","journal-title":"Rev Med Interne"},{"issue":"4","key":"10.1016\/j.rdc.2016.03.002_bib85","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/rheumatology\/32.4.297","article-title":"Patients with anticentromere antibodies, clinical features, diagnoses and evolution","volume":"32","author":"Vlachoyiannopoulos","year":"1993","journal-title":"Br J Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2016.03.002_bib86","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.77.3.1627","article-title":"Autoantibody to centromere (kinetochore) in scleroderma sera","volume":"77","author":"Moroi","year":"1980","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.rdc.2016.03.002_bib87","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1172\/JCI112320","article-title":"Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies","volume":"77","author":"Earnshaw","year":"1986","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.rdc.2016.03.002_bib88","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/art.10407","article-title":"Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss","volume":"46","author":"Schachna","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2016.03.002_bib89","first-page":"1121","article-title":"Centromere protein C is a target of autoantibodies in Sj\u00f6gren's syndrome and is uniformly associated with antibodies to Ro and La","volume":"31","author":"Pillemer","year":"2004","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2016.03.002_bib90","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/ard.2005.046003","article-title":"Distinct recognition of antibodies to centromere proteins in primary Sj\u00f6gren's syndrome compared with limited scleroderma","volume":"65","author":"Gelber","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2016.03.002_bib91","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10067-012-2005-5","article-title":"Potential diagnostic utility of anti-centromere antibody in primary Sj\u00f6gren's syndrome in the UK","volume":"31","author":"Collins","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2016.03.002_bib92","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.semarthrit.2005.12.004","article-title":"Atypical autoantibodies in patients with primary Sj\u00f6gren syndrome: clinical characteristics and follow-up of 82 cases","volume":"35","author":"Ramos-Casals","year":"2006","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2016.03.002_bib93","first-page":"608","article-title":"Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sj\u00f6gren's syndrome","volume":"34","author":"Barcelos","year":"2009","journal-title":"Acta Reumatol Port"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib94","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.2003.019794","article-title":"Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sj\u00f6gren's syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib95","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3899\/jrheum.080193","article-title":"Determination of the subset of Sj\u00f6gren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies","volume":"36","author":"Iwamoto","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2016.03.002_bib96","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.2004.029603","article-title":"Anti-cyclic citrullinated peptide antibodies in patients with primary Sj\u00f6gren's syndrome","volume":"64","author":"Tobon","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"1\u20132","key":"10.1016\/j.rdc.2016.03.002_bib97","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2011.11.005","article-title":"Primary biliary cirrhosis and Sj\u00f6gren's syndrome: autoimmune epithelitis","volume":"39","author":"Selmi","year":"2012","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.rdc.2016.03.002_bib98","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3109\/14397595.2013.865823","article-title":"Diagnostic accuracy of anti-alpha-fodrin antibodies for primary Sj\u00f6gren's syndrome","volume":"24","author":"Qin","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2016.03.002_bib99","first-page":"1088","article-title":"Discrimination between Sj\u00f6gren's and non-Sj\u00f6gren's sicca syndrome by sialoscintigraphy and antibodies against alpha-fodrin and Ro\/La autoantigens","volume":"37","author":"Chen","year":"2009","journal-title":"J\u00a0Int Med Res"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib100","first-page":"49","article-title":"Autoantibodies to alpha-fodrin in primary Sj\u00f6gren's syndrome and SLE detected by an in\u00a0vitro transcription and translation assay","volume":"21","author":"Nordmark","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2016.03.002_bib101","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/ar1021","article-title":"Anti-alpha-fodrin antibodies do not add much to the diagnosis of Sj\u00f6gren's syndrome","volume":"6","author":"Zandbelt","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2016.03.002_bib102","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.2741\/3484","article-title":"Autoantibody to NA14 is an independent marker primarily for Sj\u00f6gren's syndrome","volume":"14","author":"Nozawa","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"6","key":"10.1016\/j.rdc.2016.03.002_bib103","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/s10165-009-0215-8","article-title":"Anti-proteasome activator 28alpha is a novel anti-cytoplasmic antibody in patients with systemic lupus erythematosus and Sj\u00f6gren's syndrome","volume":"19","author":"Matsushita","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2016.03.002_bib104","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clim.2012.09.013","article-title":"Novel autoantibodies in Sj\u00f6gren's syndrome","volume":"145","author":"Shen","year":"2012","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2016.03.002_bib105","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/art.39497","article-title":"Primary Sj\u00f6gren's syndrome patients with autoantibodies against TRIM38 show greater severity of disease","volume":"68","author":"Wolska","year":"2016","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16300138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16300138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:14:38Z","timestamp":1760181278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X16300138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":105,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0889857X16300138"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2016.03.002","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies in Sj\u00f6gren\u2019s Syndrome","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2016.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}